Where to be

Updated: 10 can't-miss innovation events for January

From enlightening talks to anniversary celebrations, here's where you need to be in January. Getty Images

Houston's innovation community is starting 2019 strong with plenty of business professional events.

If you know of innovation-focused events for February, email me at natalie@innovationmap.com with the details.

1. How to Start a Startup with Roberto Moctezuma, founder & CEO of Fractal River

Thinking 2019 is the year you finally turn your business idea into a startup? Station Houston wants to help. It's free to attend this discussion lead by Roberto Moctezuma, the founder and CEO of Houston-based Fractal River, an advisory firm. The talk will focus on identifying problems, determining market needs, learning important metrics, and more.

The event is from 6 to 7 pm on Tuesday, January 8, at Station Houston (1301 Fannin St., Suite 2440).

Learn more here.

2. January U.S. Oil & Gas Blockchain Forum Luncheon

For the first event of the year, the U.S. Oil & Gas Blockchain Forum is focusing on how blockchain can help the energy industry. Guest speakers are Andrew Bruce, CEO and founder of Houston-based Data Gumbo, and Rebecca Hofmann, blockchain strategist at Equinor.

The luncheon is from 11:30 am to 1:30 pm on Tuesday, January 15, at the Equinor Auditorium (2107 CityWest Blvd). Tickets to attend are $50.

Learn more here.

3. Salesforce Essentials Workshop: Houston

Attention small business owners: Salesforce has a workshop designed for you. Learn about the platform and how it can help your business strategy over lunch.

The workshop isn Tuesday, January 15, from noon to 2 p.m. at The Cannon (1336 Brittmoore Road) and is free to attend.

Learn more here.

4. Society of Petroleum Engineers Women-in-Energy Congress

Energy industry ladies take center stage of a full-day event focused on women in oil and gas. Susan Dio, chairman and president of BP America, will deliver the keynote address before the rest of the day's panels and presentations begin.

This event is January 18, from 8 a.m. to 3:30 p.m., at the Houston Community College West Houston Institute (2811 Hayes Road).

Learn more here.

5. Houston Startup Demo Day

Three Houston startups will present their product and business plan at The Station's monthly demo day. The companies and judges are still being determined, but the event details are finalized.

Hear the pitches on Wednesday, January 23, from 6 to 8 p.m., at Station Houston (1301 Fannin Street, Suite 2440). The event is free to attend.

Learn more here.

6. NRLC Workshop: Pitching Part 2: The Physical Pitch with Beth O'Sullivan

If you thought you were pitch perfect, think again. Beth O'Sullivan, a management senior lecturer at Rice University's Jones Graduate School of Business, is giving a free lecture on the art of pitching your company. The Liu Idea Lab for Innovation and Entrepreneurship is offering the event.

The lecture will be from 4 to 5:30 pm on Wednesday, January 23, at the Liu Idea Lab for Innovation and Entrepreneurship (6100 Main Street Cambridge Office Building, Suite 130).

Learn more here.

7. Women Entrepreneurs Pitch Party at The Cannon

Calling all angel investors — The Cannon Ventures would like to introduce you to a few female entrepreneurs this month. InnovationMap is a media partner for the event, and the goal is to generate connections between the entrepreneurs and potential investors.

The event takes place on Thursday, January 24, from 6:30 to 9 p.m. at The Cannon (1336 Brittmoore Road).

If you're an interested investor and would like to attend, email Jake Askew at jaskew@cannonventureshouston.com.

8. Oil & Gas Happy Hour Hosted by OGGN + The Cannon

Grab a beer and some bites at Oil & Gas Global Network's monthly happy hour — this time in collaboration with Houston-based The Cannon.

Join oil and gas professionals at The Cannon (1336 Brittmoore Road) on Tuesday, January 29, from 6 to 9 p.m. Tickets are $10 for this happy hour event, and proceeds go to Redeemed Ministries, a local charity to help human trafficking victims.

Learn more here.

9. Station Houston 3.0 and Launch Party

As Station Houston officially becomes a nonprofit on January 1, and, in preparation for its move to the Midtown Innovation District, the organization is revealing Station Houston 3.0 to start 2019 with. The free event is Wednesday, January 30, from 6 to 8 pm at Station Houston (1301 Fannin St., Suite 2440).

Guests can mingle until the short program and announcement, which is followed by light bites. Station will also be showing off Houston's first VR Lab and its new space.

Learn more here.

10. Inaugural meeting of the Houston Industrial Digital Transformation & IoT Meetup

Calling all digital and tech innovation leaders in oil and gas or utilities — there's a new group for you to join. The Houston Industrial Digital Transformation and IoT Meetup formed to bring leaders of industrial innovation together for collaboration and so that they can learn from each other's digital transformations.

The inaugural meetup is from 6 to 8 pm on Wednesday, January 30, at ChaiOne HQ (9 Greenway Plaza, Suite 850). It's free to attend.

Learn more here.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted